CBG, CBC, CBN, and CBDV have shown promise as anti-cancer agents in the treatment of blood cancer.
A Canadian cannabis company is set to study minor cannabinoids for the treatment of epilepsy as part of a National Institute of Health (NIH) programme. Cannabis...